Drugs / 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06395688 | Dec 2025 → Jun 2026 | substance abuse | Aelis Farma | Withdrawn | No outcome recorded |
| Phase 1 | NCT05451017 | Jan → Jun 2023 | substance abuse | Aelis Farma | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06395688 ↗ |